| Diabetes and kidney disease: role of oxidative stress C JhaJay, SM ChowBryna, E CooperMark Antioxidants & redox signaling, 2016 | 540 | 2016 |
| Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy JC Jha, SP Gray, D Barit, J Okabe, A El-Osta, T Namikoshi, ... Journal of the American Society of Nephrology 25 (6), 1237-1254, 2014 | 368 | 2014 |
| miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7 AD McClelland, M Herman-Edelstein, R Komers, JC Jha, CE Winbanks, ... Clinical Science 129 (12), 1237-1249, 2015 | 237 | 2015 |
| Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b B Wang, JC Jha, S Hagiwara, AD McClelland, K Jandeleit-Dahm, ... Kidney international 85 (2), 352-361, 2014 | 198 | 2014 |
| A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes JC Jha, F Ho, C Dan, K Jandeleit-Dahm Clinical Science 132 (16), 1811-1836, 2018 | 151 | 2018 |
| Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy JC Jha, V Thallas-Bonke, C Banal, SP Gray, BSM Chow, G Ramm, ... Diabetologia 59 (2), 379-389, 2016 | 146 | 2016 |
| NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy JC Jha, C Banal, J Okabe, SP Gray, T Hettige, BSM Chow, ... Diabetes 66 (10), 2691-2703, 2017 | 142 | 2017 |
| Oxidative stress, Nox isoforms and complications of diabetes—potential targets for novel therapies M Sedeek, AC Montezano, RL Hebert, SP Gray, E Di Marco, JC Jha, ... Journal of cardiovascular translational research 5, 509-518, 2012 | 138 | 2012 |
| Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy V Thallas‐Bonke, JC Jha, SP Gray, D Barit, H Haller, HHHW Schmidt, ... Physiological reports 2 (11), e12192, 2014 | 124 | 2014 |
| Oxidative stress and inflammation in renal and cardiovascular complications of diabetes A Charlton, J Garzarella, KAM Jandeleit-Dahm, JC Jha Biology 10 (1), 18, 2020 | 118 | 2020 |
| Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno-and atheroprotection even in established micro-and macrovascular disease SP Gray, JC Jha, K Kennedy, E Van Bommel, P Chew, C Szyndralewiez, ... Diabetologia 60, 927-937, 2017 | 115 | 2017 |
| Are reactive oxygen species still the basis for diabetic complications? ED Marco, JC Jha, A Sharma, JL Wilkinson-Berka, KA Jandeleit-Dahm, ... Clinical Science 129 (2), 199-216, 2015 | 99 | 2015 |
| The emerging role of NADPH oxidase NOX5 in vascular disease JC Jha, AMD Watson, G Mathew, LC de Vos, K Jandeleit-Dahm Clinical Science 131 (10), 981-990, 2017 | 64 | 2017 |
| New insights into the use of biomarkers of diabetic nephropathy JC Jha, KAM Jandeleit-Dahm, ME Cooper Advances in chronic kidney disease 21 (3), 318-326, 2014 | 58 | 2014 |
| Dyslipidemia, diabetes and atherosclerosis: role of inflammation and ROS-redox-sensitive factors E Hasheminasabgorji, JC Jha Biomedicines 9 (11), 1602, 2021 | 54 | 2021 |
| Nox (NADPH oxidase) 1, Nox4, and Nox5 promote vascular permeability and neovascularization in retinopathy D Deliyanti, SF Alrashdi, RM Touyz, CR Kennedy, JC Jha, ME Cooper, ... Hypertension 75 (4), 1091-1101, 2020 | 50 | 2020 |
| NADPH oxidase inhibition: preclinical and clinical studies in diabetic complications S Urner, F Ho, JC Jha, D Ziegler, K Jandeleit-Dahm Antioxidants & redox signaling 33 (6), 415-434, 2020 | 48 | 2020 |
| Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse JC Jha, A Dai, CE Holterman, ME Cooper, RM Touyz, CR Kennedy, ... Diabetologia 62, 1712-1726, 2019 | 39 | 2019 |
| Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes C Gueguen, SL Burke, B Barzel, N Eikelis, AMD Watson, JC Jha, ... Diabetologia 63, 1424-1434, 2020 | 32 | 2020 |
| A study of oxidative stress, antioxidant status and lipid profile in diabetic patient in the western region of Nepal. BR Maharjan, JC Jha, D Adhikari, P Vishwanath, J Baxi, VM Alurkar, ... Kathmandu University medical journal (KUMJ) 6 (1), 16-22, 2008 | 32 | 2008 |
